MedPath
HSA Approval

Risedronate Mevon film-coated tablets 35mg

SIN13798P

Risedronate Mevon film-coated tablets 35mg

Risedronate Mevon film-coated tablets 35mg

May 14, 2010

NOVEM PHARMA PRIVATE LIMITED

NOVEM PHARMA PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM PHARMA PRIVATE LIMITED
Licence HolderNOVEM PHARMA PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

M05BA07

risedronic acid

Manufacturer Information

NOVEM PHARMA PRIVATE LIMITED

Pharmathen S.A.

Active Ingredients

RISEDRONATE SODIUM HEMIPENTAHYDRATE 40.17 mg EQV RISEDRONATE SODIUM

35 mg

Risedronic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Risedronate Mevon film-coated tablets 35mg - HSA Approval | MedPath